Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV-2 vaccine in liver transplant recipients.

Lucy MeunierMathilde SanavioJérôme Dumortier Magdalena MeszarosStéphanie FaureJosé Ursic BedoyaMaxime EchenneOlivier BoillotAntoine DebourdeauGeorges Philippe Pageaux

Published in: Liver international : official journal of the International Association for the Study of the Liver (2022)

Even after a third booster dose, response rate to vaccination is decreased in liver transplant recipients. MMF appears to be a major determinant of seroconversion and optimal response to vaccination in these patients.

Keyphrases

sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
immune response
patient reported outcomes